Carney announces steel import crackdown
News
Duration 4:17
As part of efforts to support Canada's steel industry in the face of U.S. tariffs, Prime Minister Mark Carney outlined a plan to crack down on cheap, foreign steel imports.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
27 minutes ago
- Globe and Mail
Outlook Therapeutics Participates in the Virtual Investor 'What's Your Story' Summer Spotlight On-Demand Conference
Video webcast now available on-demand ISELIN, N.J., July 22, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, today announced that Bob Jahr, newly appointed Chief Executive Officer, participated in the Virtual Investor 'What's Your Story' Summer Spotlight On-Demand Conference. As part of the event, Mr. Jahr dove deeper into what brought him to Outlook Therapeutics, how he got to where he is today and provided insight into why he is excited about the future for Outlook Therapeutics. The on-demand video webcast is now available on as well as the Events page under the Investors section of the Company's website ( About Outlook Therapeutics, Inc. Outlook Therapeutics is a biopharmaceutical company focused on the development and commercialization of ONS-5010/LYTENAVA™ (bevacizumab-vikg; bevacizumab gamma) to enhance the standard of care for bevacizumab for the treatment of retina diseases. LYTENAVA™ (bevacizumab gamma) is the first ophthalmic formulation of bevacizumab to receive European Commission and MHRA Marketing Authorization for the treatment of wet AMD. Outlook Therapeutics commenced commercial launch of LYTENAVA™ (bevacizumab gamma) in Germany and the UK as a treatment for wet AMD. In the United States, ONS-5010/LYTENAVA™ (bevacizumab-vikg) is investigational, and a BLA has been resubmitted to the FDA. If approved in the United States, ONS-5010/LYTENAVA™, would be the first approved ophthalmic formulation of bevacizumab for use in retinal indications, including wet AMD. Jenene Thomas
National Post
27 minutes ago
- National Post
AXL teams with RSM Canada to build AI solutions for Canada's future
Article content TORONTO — AXL, a Canadian venture studio transforming world-class applied AI research into high-growth companies, and RSM Canada LLP ('RSM'), a leading global provider of assurance, tax and consulting services, have entered into a strategic collaboration. Together, the two organizations are driving innovation by challenging existing models and reimagining what's possible in professional services by integrating AI advancements with real-world business needs. Article content As part of the collaboration, RSM will serve as the exclusive provider of accounting, tax and consulting services to AXL, offering strategic guidance, compliance expertise, and growth planning support. Additionally, RSM will act as a preferred provider of these services to AXL's portfolio of startup companies. Article content RSM is also one of several leading Canadian organizations participating in AXL's AI Catalyst program, a corporate partnership initiative designed to validate and accelerate breakthrough ideas driven by real industry demand. The goal is to fast-track the commercialization of high-potential AI applications and ensure Canadian innovations are built into the country's economic future, rather than being exported before they scale. Article content 'Canada doesn't have an innovation gap, it has a commercialization gap,' says Dr. Daniel Wigdor, co-founder and CEO of AXL. 'With RSM, we're taking demand signals from the market and moving fast to turn that into scalable, enterprise-ready solutions. This is execution over hype. This is how Canada leads—not just in ideas, but in outcomes.' Article content Canada leads in AI academic research but struggles to retain its economic benefits, as much of its advancements are commercialized internationally. Article content Fewer than 20 per cent of mid-sized Canadian companies have begun adopting AI, according to the OECD, citing barriers such as limited technical talent, high costs and an uncertain return on investment. These findings are echoed in RSM's 2025 Middle Market AI Survey, which highlights similar challenges and underscores the need for practical, scalable AI solutions tailored to the middle market. Article content Meanwhile, nearly 75 per cent of AI patents from Canada's top institutes are acquired by international tech firms, with only 7 per cent remaining in the country. The United Nations also estimates that fewer than half of Canada's top AI innovations are ever patented, highlighting a critical disconnect between invention and impact. Article content By integrating real-time industry feedback, the AXL-RSM collaboration advances Canadian AI venture growth, commercialization and talent development, ensuring solutions scale domestically and drive lasting economic impact. Article content 'We're seeing incredible momentum around AI and the value it can unlock,' said Harry Blum, national managing partner at RSM Canada. 'With AXL as a strategic collaborator, we're accelerating innovation—helping businesses move beyond legacy models and positioning them to grow, compete and thrive in a future-ready economy, while embedding AI across our own solution sets.' Article content The relationship represents a direct commitment to Canada's AI ecosystem, powering homegrown innovation while reinforcing a shared commitment to helping Canadian businesses lead in the digital economy. RSM recently committed US$1 billion globally to AI, with a focus on helping middle market businesses adopt AI, especially those ready to innovate but lacking scale or resources. This initiative by RSM further aligns with AXL's vision of positioning Canada as a global leader in applied AI by bridging the gap between research and commercialization. Article content Together, AXL and RSM aim to unlock the next wave of AI-driven economic growth, bringing AI solutions that empower Canadian businesses and proving the benefit of AI not just in theory but in practice. Article content To learn more about how AXL is fuelling Canada's AI research-to-commercialization pipeline, visit their website at Article content About AXL Article content AXL is a Canadian venture studio transforming world-class research into high-growth companies that shape the future of applied AI. Led by seasoned tech entrepreneurs and applied AI experts, AXL's mission is to ensure Canada's top breakthroughs are built and scaled at home. By connecting academia with real market demand and full-stack venture creation, AXL helps Canada move from invention to impact, anchoring talent, intellectual property, and long-term economic value within the country. For more information, visit and connect with us on Article content About RSM Canada Article content RSM empowers middle market companies worldwide to take charge of change. The clients we serve are the engine of global commerce and economic growth. Our unique middle market perspective makes RSM the natural choice for growth-oriented, internationally active organizations seeking relevant insights and tailored, innovative solutions for a complex and changing world. With a global reach spanning more than 120 countries, we instill confidence in a world of change by bringing the full power of RSM to make a lasting impact on our clients, colleagues and communities. Article content RSM Canada LLP provides public accounting services and is the Canadian member firm of RSM International, a global network of independent assurance, tax and consulting firms. RSM Canada Consulting LP provides consulting services and is an affiliate of RSM US LLP, a member firm of RSM International. For more information visit like us on Facebook, follow us on X and/or connect with us on LinkedIn. Article content Article content Article content Article content Contacts Article content For media inquiries: Article content Article content Article content Article content
CTV News
27 minutes ago
- CTV News
U.S. Justice Department wants to interview Jeffrey Epstein's former girlfriend Ghislaine Maxwell
Audrey Strauss, acting U.S. attorney for the Southern District of New York, points to a photo of Jeffrey Epstein and Ghislaine Maxwell, during a news conference in New York on July 2, 2020. (AP Photo/John Minchillo, File) WASHINGTON — The U.S. Department of Justice wants to interview Jeffrey Epstein's former girlfriend, who was convicted of helping the financier sexually abuse underage girls and is now serving a lengthy prison sentence, a senior official said Tuesday. If Ghislaine Maxwell 'has information about anyone who has committed crimes against victims, the FBI and the DOJ will hear what she has to say,' Deputy Attorney General Todd Blanche said in a post on X, adding that President Donald Trump 'has told us to release all credible evidence." A lawyer for Maxwell confirmed there were discussions with the government. The overture to attorneys for Maxwell, who in 2022 was sentenced to 20 years in prison, is part of an ongoing Justice Department effort to cast itself as transparent following fierce backlash from parts of Trump's base over an earlier refusal to release additional records in the Epstein investigation. As part of that effort, the Justice Department, acting at the direction of the Republican president, last week asked a judge to unseal grand jury transcripts from the case. That decision is ultimately up to the judge. Epstein, who killed himself in his New York jail cell in 2019 while awaiting trial, sexually abused children hundreds of times over more than a decade, exploiting vulnerable girls as young as 14, authorities say. He couldn't have done so without the help of Maxwell, his longtime companion, prosecutors say. The Justice Department had said in a two-page memo this month that it had not uncovered evidence to charge anyone else in connection with Epstein's abuse. But Blanche said in his social media post that the Justice Department 'does not shy away from uncomfortable truths, nor from the responsibility to pursue justice wherever the facts may lead.' He said in his post that, at the direction of Attorney General Pam Bondi, he has 'communicated with counsel for Ms. Maxwell to determine whether she would be willing to speak with prosecutors from the Department.' He said he anticipated meeting with Maxwell in the coming days. A lawyer for Maxwell, David Oscar Markus, said Tuesday in a statement: 'I can confirm that we are in discussions with the government and that Ghislaine will always testify truthfully. We are grateful to President Trump for his commitment to uncovering the truth in this case.' ___ Eric Tucker, The Associated Press
